Pharma & Life Sciences
Drug development, clinical trials and the business of life sciences.
-
Triple-Agonists and CRISPR Pivotal Trials Drive Major Shift in Biopharma Pipeline Strategy
Pivotal Phase III readouts for triple-agonist metabolic therapies and clinical CRISPR platforms are setting new benchmarks for biopharma drug development strategies.
-
From Random Screening to Computational Design
For decades, biopharma R&D operated under the shadow of “Eroom’s Law”—the trend where drug discovery becomes slower and more expensive over time despite technological…